OnKure Therapeutics (OKUR) Current Assets (2020 - 2026)

OnKure Therapeutics (OKUR) has reported Current Assets for 7 consecutive years, with $177.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 110.14% year-over-year to $177.7 million; the trailing twelve-month figure through Jun 2026 stood at $177.7 million (up 110.14% YoY), and the FY2025 full-year result was $60.8 million, down 46.16% from the prior year.
• Current Assets fell to $177.7 million in Q2 2026 per OKUR's latest filing, from $197.5 million in the prior quarter.
• Across five years, Current Assets topped out at $197.5 million in Q1 2026 and bottomed at $33.8 million in Q4 2023.
• Historically, Current Assets has averaged $108.3 million across 5 years, with a median of $102.3 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Assets plunged 68.25% in 2023, then soared 234.67% in 2024.
• Over 5 years, Current Assets stood at $106.4 million in 2022, then slumped by 68.25% to $33.8 million in 2023, then jumped by 234.67% to $113.0 million in 2024, then sank by 46.16% to $60.8 million in 2025, then soared by 192.04% to $177.7 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $177.7 million, $197.5 million, and $60.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.